Home Suzanne Lepage

The drug pipeline is full of new medications that may be more effective but may also be more expensive than existing treatments. Although they could significantly improve a benefits plan member’s health, they could also render a plan unaffordable. “Because drugs represent a significant portion of group insurance plan costs, plan sponsors are concerned about […]

  • January 24, 2022 January 24, 2022
  • 07:58

The coronavirus pandemic and the changing environment have impacted pharmaceutical manufacturer-sponsored patient support programs. Manufacturers offer patient support programs to help individuals access their medication and navigate the health-care system, according to Sandra Anderson, senior vice-president of commercialization and strategy at Innomar Strategies, speaking during a session at Benefits Canada‘s Face to Face in Drug […]

  • January 24, 2022 January 24, 2022
  • 07:57

A growing number of organizations are moving beyond compliance to foster diversity, equity and inclusion in their workplaces. According to research, companies that have embraced a DEI strategy improved their bottom line with a 53 per cent return on equity, a 42 per cent return on sales, in addition to being 70 per cent more […]

  • January 24, 2022 January 24, 2022
  • 07:56

One in five Canadians will experience a mental illness in their lifetime and by age 40 about 50 per cent of the population will have or have had one. Mental illness includes conditions such as depression, schizophrenia or bipolar disorder, which “can really affect the ability of an individual to function,” said Nida Mian, senior […]

  • January 24, 2022 January 24, 2022
  • 07:54

In 2020, members of the Canadian Life and Health Insurance Association spent $650 million on drugs for rare diseases for more than 13,000 patients. Rare diseases affect one in 12 Canadians and between 6,000 and 8,000 rare diseases are known globally. In addition, roughly 80 per cent of these diseases occur in children and only […]

  • January 24, 2022 January 24, 2022
  • 07:53

The World Health Organization has designated diabetes as the only non-viral epidemic and diabetes drugs continue to be ranked as the second highest cost category for private drug plans, said Lisa Maks, clinical nurse specialist at Juravinski Hospital and St. Peter’s Hospital sites, during a session at Benefits Canada’s 2021 Mental Health Summit. Eight per cent […]

  • December 9, 2021 December 6, 2021
  • 15:56

Pharmacogenetic testing has become a popular addition to employee benefits packages, primarily because of its ability to inform personalized drug treatment, especially in mental health where it can be challenging to find an appropriate treatment and dosage that’s effective without causing side-effects. Many patients end up trying multiple medications and dosages without achieving improved outcomes, […]

  • December 9, 2021 December 6, 2021
  • 15:55

Approximately two in five Canadians live with a mental-health disorder and about eight million are struggling with non-prescriptive addiction. Medically managed intensive outpatient programming, or MMIOP, provides rapid access to treatment, resolution of symptoms and rapid return to work, said Dr. Rob Tanguay, vice-president and chief medical officer at the Newly Institute, during a session […]

  • December 9, 2021 December 8, 2021
  • 15:54

Mental health is a major pandemic in and of itself, with surveys showing a 300 per cent increase in people reporting symptoms of anxiety and depression during the coronavirus pandemic. Despite the availability of hundreds of drug treatments, rates of mental illness continue to increase and “there hasn’t been any pharmacotherapy innovation for mental illness,” […]

  • December 9, 2021 December 8, 2021
  • 15:46

The proposed amendments to the patented medicines regulations by the Patented Medicine Prices Review Board could have a big impact on both the group insurance and pharmaceutical industry. “The CLHIA is very supportive of PMPRB adjustments that may be coming,” said Joan Weir, director of health and disability policy at the Canadian Life and Health […]

  • November 22, 2021 November 22, 2021
  • 09:00